Home /
-
The threat of multi-drug resistant tuberculosis
TB kills more than 1 million people each year, and resistance to effective treatment is on the rise.
-
The rise of antifungal resistance
Stakeholders must decide how to balance food security with antifungal drug development for humans.
-
AMR-related risks and opportunities for investors
Investors with US$13.9 trillion in assets signed a statement urging policymakers to act on critical requests to tackle AMR.
-
Developing new antibiotics to combat AMR: why Netflix-like incentives could be key
The push and pull ideas helping to bring new antibiotics to market.
-
Funding research to combat AMR
Investors contribute more than just money.